GL1X · GenesisL1 explorer

MolNFT v1 · #160009 · protein

Co-crystal structure of human SMYD3 with isoxazole amides inhibitors

6P7Z · Histone-lysine N-methyltransferase SMYD3: “Co-crystal structure of human SMYD3 with isoxazole amides inhibitors”. X-ray diffraction, 4 ligands (SAM, O41, ZN), 3 pockets (best druggability 0.80). MolNFT v1 #160009 on GenesisL1: 3D…

PDB
6P7Z
Type
protein
Length
425 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Histone-lysine N-methyltransferase SMYD3
EC
2.1.1.43
UniProt
Q9H7B4
Ligands
SAM, O41, ZN, MG
Pockets
3 · best druggability 0.80

Structure

x-ray diffraction · 1 distinct chain · 52% helix, 13% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AHistone-lysine N-methyltransferase SMYD3 (EC 2.1.1.43)protein42552% helix, 13% strandQ9H7B4

Ligands and binding sites

  • SAM · S-adenosylmethionine · ligand · chains A
  • O41 · 5-cyclopropyl-N-[1-(methylsulfonyl)piperidin-4-yl]-1,2-oxazole-3-carboxamide · ligand · chains A
  • ZN · Zinc ion · metal · 3 copies · chains A
  • MG · Magnesium ion · metal · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
111080.800.81100SAM, O41
21400.510.7921empty
31260.480.7926empty

Compared structures

  • 6P7Z · Co-crystal Structure of human SMYD3 with Isoxazole Amides Inhibitors · the same entry in another collection · chain A against A, TM-score 1.00
  • Q9H7B4 · AlphaFold monomer V2.0 prediction for histone-lysine N-methyltransferase SMYD3 (Q9H7B4) · a predicted model of the same protein · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.